Review of two phase III randomized trials of single-agent docetaxel in previously treated advanced non--small cell lung cancer. [electronic resource]
Producer: 20010726Description: 5-9 p. digitalISSN:- 0093-7754
- Antineoplastic Agents, Alkylating -- therapeutic use
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Clinical Trials, Phase III as Topic
- Docetaxel
- Humans
- Ifosfamide -- therapeutic use
- Lung Neoplasms -- drug therapy
- Paclitaxel -- analogs & derivatives
- Quality of Life
- Radiation-Sensitizing Agents -- therapeutic use
- Randomized Controlled Trials as Topic
- Survival Rate
- Taxoids
- Vinblastine -- analogs & derivatives
- Vinorelbine
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.